British Columbia becomes second province to sign pharmacare agreement
Agile licensing, risk, biologics, and more: Wide-ranging amendments to Canada’s drug and medical device regulations
National pharmacare in Canada: First-ever funding agreement announced
Drug shortages: New requirements proposed for the Food and Drug Regulations
Pharma in Brief’s 2024 Year in Review and Trends for 2025
Recent developments in Canadian national pharmacare and funding for drugs for rare diseases
Federal Court denies samples for testing infringement of biologic process patent
Federal Court updates Guidelines for PMNOC proceedings
Pharmacare: Committee of Experts established
Subscribe: Subscribe via RSS
Blogs
Firm/Org